Key Highlights
•
Automated insulin delivery (AID) is beneficial for adults with insulin-treated type 2 diabetes, regardless of the presence of GAD65 antibodies. This finding supports the broader application of AID systems to improve glycemic control in this patient population.
Source →
Stay curious. Stay informed —
Science Briefing
